» Articles » PMID: 17502613

In Vitro Erythropoiesis from Bone Marrow-derived Progenitors Provides a Physiological Assay for Toxic and Mutagenic Compounds

Overview
Specialty Science
Date 2007 May 16
PMID 17502613
Citations 31
Authors
Affiliations
Soon will be listed here.
Abstract

The goal of this study was to create an in vitro cell culture system that captures essential features of the in vivo erythroid micronucleus (MN) genotoxicity assay, thus enabling increased throughput and controlled studies of the hematopoietic DNA damage response. We show that adult bone marrow (BM) cultures respond to erythropoietin, the principal hormone that stimulates erythropoiesis, with physiological erythropoietic proliferation, differentiation, and enucleation. We then show that this in vitro erythropoietic system clearly signals exposure to genotoxicants through erythroid MN formation. Furthermore, we determined that DNA repair-deficient (MGMT(-/-)) BM displayed sensitivity to genotoxic exposure in vivo compared with WT BM and that this phenotypic response was reflected in erythropoietic cultures. These findings suggest that this in vitro erythroid MN assay is capable of screening for genotoxicity on BM in a physiologically reflective manner. Finally, responses to genotoxicants during erythroid differentiation varied with exposure time, demonstrating that this system can be used to study the effect of DNA damage at specific developmental stages.

Citing Articles

DDX41 haploinsufficiency causes inefficient hematopoiesis under stress and cooperates with p53 mutations to cause hematologic malignancy.

Stepanchick E, Wilson A, Sulentic A, Choi K, Hueneman K, Starczynowski D Leukemia. 2024; 38(8):1787-1798.

PMID: 38937548 PMC: 11286521. DOI: 10.1038/s41375-024-02304-9.


IL-18 Binding Protein-Producing Cells Attenuate Anemia in Murine Macrophage Activation Syndrome.

Harel M, Fauteux-Daniel S, Rodriguez E, Palmer G, Gabay C J Immunol. 2023; 210(11):1790-1803.

PMID: 37074208 PMC: 7614543. DOI: 10.4049/jimmunol.2300065.


Arsenic impairs the lineage commitment of hematopoietic progenitor cells through the attenuation of GATA-2 DNA binding activity.

Medina S, Zhang H, Santos-Medina L, Wan G, Bolt A, Zhou X Toxicol Appl Pharmacol. 2022; 452:116193.

PMID: 35961411 PMC: 9583771. DOI: 10.1016/j.taap.2022.116193.


eIF6 rebinding dynamically couples ribosome maturation and translation.

Jaako P, Faille A, Tan S, Wong C, Escudero-Urquijo N, Castro-Hartmann P Nat Commun. 2022; 13(1):1562.

PMID: 35322020 PMC: 8943182. DOI: 10.1038/s41467-022-29214-7.


Arsenite and monomethylarsonous acid disrupt erythropoiesis through combined effects on differentiation and survival pathways in early erythroid progenitors.

Medina S, Bolt A, Zhou X, Wan G, Xu H, Lauer F Toxicol Lett. 2021; 350:111-120.

PMID: 34274428 PMC: 8487637. DOI: 10.1016/j.toxlet.2021.07.008.


References
1.
Zeiger E . Carcinogenicity of mutagens: predictive capability of the Salmonella mutagenesis assay for rodent carcinogenicity. Cancer Res. 1987; 47(5):1287-96. View

2.
Cornetta K, Croop J, Dropcho E, Abonour R, Kieran M, Kreissman S . A pilot study of dose-intensified procarbazine, CCNU, vincristine for poor prognosis brain tumors utilizing fibronectin-assisted, retroviral-mediated modification of CD34+ peripheral blood cells with O6-methylguanine DNA methyltransferase. Cancer Gene Ther. 2006; 13(9):886-95. DOI: 10.1038/sj.cgt.7700963. View

3.
ROMAGNA F, Staniforth C . The automated bone marrow micronucleus test. Mutat Res. 1989; 213(1):91-104. DOI: 10.1016/0027-5107(89)90035-3. View

4.
LUDLUM D . DNA alkylation by the haloethylnitrosoureas: nature of modifications produced and their enzymatic repair or removal. Mutat Res. 1990; 233(1-2):117-26. DOI: 10.1016/0027-5107(90)90156-x. View

5.
Hirai O, Miyamae Y, Fujino Y, Izumi H, Miyamoto A, Noguchi H . Prior bleeding enhances the sensitivity of the in vivo micronucleus test. Mutat Res. 1991; 264(3):109-14. DOI: 10.1016/0165-7992(91)90125-n. View